Purisys Revenue and Competitors
Estimated Revenue & Valuation
- Purisys's estimated annual revenue is currently $6.6M per year.
- Purisys's estimated revenue per employee is $201,000
Employee Data
- Purisys has 33 Employees.
- Purisys grew their employee count by 32% last year.
Purisys's People
| Name | Title | Email/Phone |
|---|---|---|
1 | General Manager Purisys, LLC and VP, R&D Noramco LLC | Reveal Email/Phone |
2 | Director, Product Development and Regulatory CMC | Reveal Email/Phone |
3 | Senior Manager, Technical Business Development | Reveal Email/Phone |
4 | Senior Manager, Program Management and External Manufacturing | Reveal Email/Phone |
5 | Senior Scientist | Reveal Email/Phone |
6 | QC Laboratory Analyst | Reveal Email/Phone |
7 | Manufacturing Technician | Reveal Email/Phone |
8 | Principal Scientist | Reveal Email/Phone |
9 | Senior Logistics Specialist | Reveal Email/Phone |
10 | Process Scientist | Reveal Email/Phone |
Purisys Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $29.7M | 148 | 8% | N/A | N/A |
#2 | $10.5M | 52 | -2% | N/A | N/A |
#3 | $11.3M | 56 | 4% | N/A | N/A |
#4 | $29.1M | 145 | 21% | N/A | N/A |
#5 | $6.8M | 34 | -6% | N/A | N/A |
#6 | $18.1M | 90 | -35% | N/A | N/A |
#7 | $48.2M | 240 | 37% | N/A | N/A |
#8 | $1.2M | 12 | 140% | $50M | N/A |
#9 | $12.5M | 62 | -9% | N/A | N/A |
#10 | $10.1M | 50 | -2% | N/A | N/A |
What Is Purisys?
Purisys is a global leader in custom synthesis of active pharmaceutical ingredients and advanced intermediates. We support pharma & biotech companies with APIs, reference standards, controlled substances, cannabinoids and cGMP clinical & niche commercial CDMO services. Formed as a spin-off from Noramco in 2019, Purisys began manufacturing in 1979 as part of Johnson & Johnson. WORLD LEADER IN PHARMACEUTICAL CANNABINOIDS & CANNABINOID REFERENCE STANDARDS Purisys produces 50+ major and minor cannabinoids, as well as degradants, metabolites & analytical standards to support our customers in this growing field. We have Drug Master Files for multiple compounds, including Dronabinol (DMF#20682), CBD (DMF# 33223), Nabilone (DMF# 35408), and have produced other cannabinoids used worldwide in IND/IMPD/NDA/ANDA filings. CUSTOM API and DRUG DEVELOPMENT & MANUFACTURING (CDMO) SERVICES FOR PHARMA & BIOTECH For clients seeking preclinical-to-commercial APIs, we provide comprehensive development, analytical and manufacturing services - including full-service clinical-to-commercial small volume & orphan drug commercial API synthesis in our FDA-inspected GMP manufacturing suites. Our custom synthesis projects include difficult-to-manufacture APIs (controlled substances, injectable-grade APIs, HPAPIs and environmentally sensitive APIs). IN-STOCK REFERENCE STANDARDS AND CUSTOM SYNTHESIS SERVICES Purisys stocks 250+ reference standards with structural elucidation and comprehensive analytical data. We ship reference standards to 30+ countries on 6 continents. We can perform rapid standards development & qualification – including custom synthesis of degradation products, metabolites and other impurities. CAPABILITIES: • Pharma grade cannabinoid APIs & reference standards • In-stock standards; custom synthesis & qualification • Excipient compatibility & formulation & solid state • cGMP manufacturing • Custom API, high potency API & labile molecule development • Method development
keywords:N/A
N/A
Total Funding
33
Number of Employees
$6.6M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Athens
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.8M | 33 | N/A | N/A |
#2 | $4M | 33 | 10% | N/A |
#3 | $4.6M | 33 | 50% | N/A |
#4 | $4.8M | 34 | 55% | N/A |
#5 | $9.6M | 34 | 0% | N/A |